Fig. 3From: Prognostic implication of serum glycated albumin for patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary interventionRestricted cubic smoothing for the risk of the primary endpoint according to the GA. The analysis was adjusted for Model 5. HR was evaluated by per 1-unit increase of GA. GA glycated albumin, MACCE major adverse cardio-cerebral eventsBack to article page